Case report: BRAF-inhibitor therapy in BRAF-mutated primary CNS tumours including one case of BRAF-mutated Rosai-Dorfman disease

Cronin, C; McLaughlin, R; Lane, L; Brett, FM; Jansen, M; Bermingham, N; Wyse, G; Grogan, L; Morris, PG; O'Reilly, S

Cronin, C (通讯作者),Cork Univ Hosp, Dept Med Oncol, Cork, Ireland.

FRONTIERS IN MEDICINE, 2022; 9 ():

Abstract

BRAF V600E oncogene mutations have been reported in multiple central nervous system (CNS) tumor types, and emerging evidence supports the use of targe......

Full Text Link